Viracta Therapeutics (VIRX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

VIRX is expected to report earnings to rise 20.00% to -30 cents per share on November 07

Viracta Therapeutics VIRX Stock Earnings Reports

Q3'24

Est.

$-0.30

Q2'24

Beat

by $0.12

Q1'24

Beat

by $0.12

Q4'23

Missed

by $0.04

Q3'23

Missed

by $0.02

The last earnings report on August 14 showed earnings per share of -25 cents, beating the estimate of -37 cents. With 184.19K shares outstanding, the current market capitalization sits at 8.75M.

View a ticker or compare two or three

Compare

VIRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VIRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of oncology therapeutics for treatment of solid and hematologic cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2533 South Coast Highway 101

Phone

+1 858 400-8470

Employees

Web

https://www.viracta.com